Vericel Corporation
VCELNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.22B
- P/E (TTM)
- 91.86
- Forward P/E
- 45.92
- Dividend yield
- -
- 52-week range
- $28.95$49.32
- Volume (live)
- -
- Avg. volume (3M)
- 549.73K
Vericel (VCEL) Stock Price & Financial Analysis
Vericel Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $41.75 - $43.00 |
|---|---|
| 52-Week High | $49.32 |
| 52-Week Low | $28.95 |
| Open | $42.99 |
| Volume (last close) | 494.73K |
| Average Volume (3M) | 549.73K |
| Revenue (TTM) | 306.30M |
|---|---|
| Net Income (TTM) | 24.22M |
| Free Cash Flow (TTM) | 49.64M |
| EPS (TTM) | $0.47 |
| Profit Margin | 7.91% |
| Operating Margin | 5.95% |
| Return on Equity (ROE) | 6.55% |
| Debt to Equity | 0.25 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 2.22B |
|---|---|
| Shares Outstanding | 52.31M |
| P/E Ratio (TTM) | 91.86 |
| Forward P/E | 45.92 |
| Price to Sales (P/S) | 7.26 |
| Price to Book (P/B) | 6.01 |
| EV/EBITDA | 60.05 |
| 50-Day MA | $40.87 |
|---|---|
| 200-Day MA | $38.50 |
| 1-Year Change | +19.39% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Vericel at a Glance
As of the Oct 23, 2026 close, Vericel (VCEL) has a market capitalization of $2.22B. The stock trades at 91.9× trailing earnings, 45.9× forward earnings and 7.3× sales. Over the trailing twelve months it earned $24.22M on revenue of $306.30M (a 7.9% profit margin) and generated $49.64M of free cash flow. Revenue grew 22.9% year over year.
As of its latest reported balance sheet, it holds $125.36M in cash and securities against $92.54M of debt, a net cash position of $32.82M.
Vericel does not currently pay a dividend.
The share price is up 19.4% over the past year. At $42.53 (the Oct 23, 2026 close) it sits within its 52-week range of $28.95 to $49.32, above its 200-day moving average of $38.50.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $60.25, 41.7% above the Oct 23, 2026 close.
Frequently Asked Questions About Vericel
What is the current stock price for VCEL?
As of the Oct 23, 2026 close, VCEL stock trades at $42.53. The 52-week range is $28.95–$49.32, with a day range of $41.75–$43.00.
What is the P/E ratio for VCEL?
As of the Oct 23, 2026 close, Vericel's trailing twelve-month (TTM) P/E ratio is 91.9, meaning investors pay $91.9 for every $1 of annual earnings. The forward P/E is 45.9, reflecting analyst expectations for future earnings. Vericel operates in the Healthcare sector.
Does VCEL pay dividends?
Vericel does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for VCEL?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for VCEL is Buy. The average 12-month price target is $60.25, a 41.7% upside from the Oct 23, 2026 close of $42.53.
What is the market cap of VCEL?
As of the Oct 23, 2026 close, Vericel's market capitalization is $2.22B, classifying it as a mid-cap company. Vericel operates in the Healthcare sector within the Biotechnology industry.